$1.46
26.96%
Nasdaq, Nov 18, 04:00 pm EST. Closed.
ISIN
US23725P1003
Symbol
DRIO

DarioHealth Corp. Stock price

$1.46
-3.03 67.48% 1M
-6.89 82.52% 6M
-9.92 87.17% YTD
-11.76 88.96% 1Y
-21.34 93.60% 3Y
-317.94 99.54% 5Y
-1,234.54 99.88% 10Y
-107,278.54 100.00% 20Y
Nasdaq, Closing price Wed, Nov 18 2026
+0.31 26.96%
ISIN
US23725P1003
Symbol
DRIO

Is DarioHealth Corp. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,085 stocks worldwide.

Key metrics

Basic
Market capitalization
$16.5m
Enterprise Value
$33.6m
Net debt
$17.1m
Cash
$14.0m
Shares outstanding
7.3m
Valuation
P/E
negative
P/S | estimate
0.8 | 0.7
EV/Sales | estimate
1.6 | 1.5
EV/FCF | ex SBC
negative | negative
P/B
0.3
Financial Health
Equity Ratio
61.7%
Return on Equity
-90.9%
ROCE
-36.6%
ROIC
-43.8%
Debt/Equity
0.6
Share-Based Compensation & Dilution
SBC | % of Revenue
$7.1m | 33.6%
SBC as % of FCF
-
SBC Growth 1Y
-27.6%
Share Count Growth 1Y
223.3%
Shareholder Yield
-
Financials
Revenue | estimate
$21.0m | $22.0m
EBITDA
$-29.7m
EBIT
$-31.8m
Net Income
$-63.0m
Free Cash Flow | ex SBC
$-25.5m | $-32.5m
Growth
Revenue | estimate
-22.7% | -1.5%
EBITDA
17.4%
EBIT
24.7%
Net Income
-48.4%
Free Cash Flow
5.4%
Margin
Gross
58.2%
EBITDA
-141.5%
EBIT
-151.6%
Net
-299.9%
Free Cash Flow | ex SBC
-121.3% | -155.0%
More
EPS
$-6.7
FCF per Share
$-3.5
Short interest
1.0%
Employees
163
Rev per Employee
$140.0k

DarioHealth Corp. Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a DarioHealth Corp. forecast:

10x Buy
83%
2x Hold
17%

Analyst Opinions

12 Analysts have issued a DarioHealth Corp. forecast:

Buy
83%
Hold
17%

DarioHealth Corp. Events

Past Events
NOV
12
Q3 2026 Earnings Call
7 days ago
AUG
11
Q2 2026 Earnings Call
3 months ago
MAY
13
Q1 2026 Earnings Call
6 months ago
MAR
19
Q4 2025 Earnings Call
8 months ago
NOV
13
Q3 2025 Earnings Call
about one year ago

Financial data from DarioHealth Corp.

Jun '26
+/-
%
21 21
23% 23%
100%
- Direct Costs 8.79 8.79
28% 28%
42%
12 12
18% 18%
58%
- Selling and Administrative Expenses 34 34
13% 13%
160%
- Research and Development Expense 10 10
44% 44%
50%
-30 -30
17% 17%
-142%
- Depreciation and Amortization 2.12 2.12
66% 66%
10%
EBIT (Operating Income) EBIT -32 -32
25% 25%
-152%
Net Profit -63 -63
48% 48%
-300%

In millions USD.

Don't miss a Thing! We will send you all news about DarioHealth Corp. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

DarioHealth Corp. Stock News

Neutral
PRNewsWire
●
about 21 hours ago
New agreement reflects rapid adoption of recently launched Dario Women™, the Company's women's health solution addressing perimenopause and menopause The Minnesota Star Tribune expands its existing relationship with Dario to amplify cardiometabolic health outcomes with comprehensive women's health support to eligible employees beginning January 2027 Nearly 45% of Dario's current book of busines...
Neutral
PRNewsWire
●
3 days ago
New methodology addresses critical market need for a transparent, replicable model to estimate healthcare cost savings and ROI when medical claims data are unavailable or delayed Further demonstrates Dario's economic value in support of new contract wins, contract renewals and expansion of existing customer relationships NEW YORK, Nov. 16, 2026 /PRNewswire/ --  DarioHealth Corp.  (NASDAQ: DRIO)...
More DarioHealth Corp. News

Company Profile

DarioHealth Corp. is a digital therapeutics company, which engages in the research, development, and sale of pharmaceutical products. It offers a monitoring device, mobile application, and data services for diabetes management. Its solutions include MyDario, Daro Engage, and Dario Intelligence. The company was founded by Oren Fuerst, Shoshana Friedman, David Weintraub, Dov Oppenheim, and Shilo Ben Zeev on August 11, 2011 and is headquartered in Caesarea, Israel.

Head office United States
CEO Mr. Raphael
Employees 163
Founded 2011
Website www.dariohealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today